Investigational Drug Details
| Drug ID: | D418 |
| Drug Name: | Eucalyptol |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB03852 |
| DrugBank Description: | Eucalyptol is naturally produced cyclic ether and monoterpenoid. Eucalyptol is an ingredient in many brands of mouthwash and cough suppressant. It controls airway mucus hypersecretion and asthma via anti-inflammatory cytokine inhibition. Eucalyptol is an effective treatment for nonpurulent rhinosinusitis. Eucalyptol reduces inflammation and pain when applied topically. It kills leukaemia cells in vitro. |
| PubChem ID: | 2758 |
| CasNo: | 470-82-6 |
| Repositioning for NAFLD: | Yes |
| SMILES: | C[C@@]12CC[C@@H](CC1)C(C)(C)O2 |
| Structure: |
|
| InChiKey: | WEEGYLXZBRQIMU-WAAGHKOSSA-N |
| Molecular Weight: | 154.2493 |
| DrugBank Targets: | |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|